Thursday, November 2, 2017

Quorum Consulting Acquired by Navigant (NYSE)

San Francisco's leading boutique pharma and healthcare consultancy, Quorum Consulting, will be acquired by Navigant for an undisclosed amount.   Navigant is traded on the New York Stock Exchange with a market cap of about $800M.  2016 revenue was about $1B.  Press release here.

In August 2015, Avalere, another life sciences/pharmacoeconomics consultancy was acquired by Inovalon for $140M.

In other news, Silicon Valley pharmacoeconomics consultancy Cedar Associates has apparently taken down its website.    John Hornberger MD is now listed as Senior Fellow at Genomic Health on LinkedIn as of October 2017.